Bio-Rad Laboratories (NYSE:BIO) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Bio-Rad Laboratories beat estimated earnings by 12.63%, reporting an EPS of $3.21 versus an estimate of $2.85.
Revenue was up $57.07 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.27, which was followed by a 0.74% increase in the share price the next day.
Here's a look at Bio-Rad Laboratories's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 2.44 | 2.66 | 3 | 3.29 |
| EPS Actual | 3.71 | 3.54 | 5.21 | 4.01 |
| Revenue Estimate | 661.87M | 631.78M | 660.98M | 686.80M |
| Revenue Actual | 715.20M | 715.93M | 726.80M | 789.84M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
